NTI 5.97% 7.1¢ neurotech international limited

Perth, Australia & Malta – 2 October 2018 – Neurotech...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,908 Posts.
    lightbulb Created with Sketch. 390
    Perth, Australia & Malta2 October 2018 – Neurotech International Limited (ASX: NTI) ("Neurotech" or "the Company") is pleased to announce that it has reached another milestone following the submission of its Federal Drug Administration (FDA) clearance application for flagship product Mente Autism.

    The Company is seeking clearance for Mente Autism using a de-novo application process and expects the approval process to take 9 – 12 months.
    Last edited by TerribleTadpole: 02/10/18
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.004(5.97%)
Mkt cap ! $64.55M
Open High Low Value Volume
6.7¢ 7.2¢ 6.7¢ $36.36K 521.1K

Buyers (Bids)

No. Vol. Price($)
2 325740 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.1¢ 38024 1
View Market Depth
Last trade - 12.16pm 22/11/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.